Skip to main content
Journal cover image

Association Between Hemoglobin Improvement and Patient-Reported Outcomes in Patients With Myelofibrosis and Anemia: Post Hoc Pooled Analysis of Momelotinib Phase 3 Trials

Publication ,  Conference
Palmer, J; Mazerolle, F; Liu, T; M'Hari, M; Regnault, A; Zhang, S; Cardellino, A; Wang, Z; Strouse, B; Sahni, J; LeBlanc, T
Published in: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
2024

Duke Scholars

Published In

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

EISSN

2152-2669

ISSN

2152-2650

Publication Date

2024

Volume

24

Start / End Page

S409 / S410

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Palmer, J., Mazerolle, F., Liu, T., M’Hari, M., Regnault, A., Zhang, S., … LeBlanc, T. (2024). Association Between Hemoglobin Improvement and Patient-Reported Outcomes in Patients With Myelofibrosis and Anemia: Post Hoc Pooled Analysis of Momelotinib Phase 3 Trials. In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (Vol. 24, pp. S409–S410).
Palmer, Jeanne, Flora Mazerolle, Tom Liu, Manal M’Hari, Antoine Regnault, Shiyuan Zhang, Anna Cardellino, et al. “Association Between Hemoglobin Improvement and Patient-Reported Outcomes in Patients With Myelofibrosis and Anemia: Post Hoc Pooled Analysis of Momelotinib Phase 3 Trials.” In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 24:S409–10, 2024.
Palmer J, Mazerolle F, Liu T, M’Hari M, Regnault A, Zhang S, et al. Association Between Hemoglobin Improvement and Patient-Reported Outcomes in Patients With Myelofibrosis and Anemia: Post Hoc Pooled Analysis of Momelotinib Phase 3 Trials. In: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2024. p. S409–10.
Palmer J, Mazerolle F, Liu T, M’Hari M, Regnault A, Zhang S, Cardellino A, Wang Z, Strouse B, Sahni J, LeBlanc T. Association Between Hemoglobin Improvement and Patient-Reported Outcomes in Patients With Myelofibrosis and Anemia: Post Hoc Pooled Analysis of Momelotinib Phase 3 Trials. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2024. p. S409–S410.
Journal cover image

Published In

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

EISSN

2152-2669

ISSN

2152-2650

Publication Date

2024

Volume

24

Start / End Page

S409 / S410

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences